GLP-1 & incretin medicines

Zepbound

tirzepatide · Dual GIP / GLP-1 receptor agonist · Eli Lilly

✓Last reviewed · Written by Dr. George Grunberger · Medical review: pending — clinician review in progress · How we review

In short

Zepbound (tirzepatide) is a dual GIP / GLP-1 receptor agonist made by Eli Lilly, used for weight reduction and long-term maintenance in adults with obesity, or overweight with a weight-related condition and moderate-to-severe obstructive sleep apnea in adults with obesity. Schedule: once weekly. It is prescription-only in the US and Canada.

FormPrefilled pen or single-dose vial, subcutaneous injection
How oftenOnce weekly
United StatesFDA-approved.
CanadaThe Zepbound name is US-specific; in Canada tirzepatide is marketed as Mounjaro. Check the Drug Product Database.
PrescriptionRequired
⚠ Boxed warning: risk of thyroid C-cell tumors. Do not use if you or a family member has had medullary thyroid carcinoma (MTC) or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

What it is used for

  • Weight reduction and long-term maintenance in adults with obesity, or overweight with a weight-related condition
  • Moderate-to-severe obstructive sleep apnea in adults with obesity

Zepbound dosage

Per the official label. Your prescriber sets your dose — never change it on your own.

Zepbound label dosing schedule
1Weeks 1–42.5 mg weekly (starter)
2Week 5 on5 mg weekly
3If neededIncrease by 2.5 mg every 4 weeks
4Maintenance5, 10 or 15 mg weekly (sleep apnea: 10 or 15 mg)
5Maximum15 mg weekly
Zepbound dose stepsWeeks 1–4: 2.5 mg; Week 5 on: 5 mg; Maximum: 15 mg2.5 mgWeeks 1–45 mgWeek 5 on15 mgMaximum
Zepbound label titration, step by step. Doses go up only as tolerated and as your prescriber decides.

How to take it

Inject under the skin of the stomach, thigh or upper arm once weekly.

Storage

Refrigerate. Pens/vials may be kept unrefrigerated up to 86°F (30°C) for up to 21 days.

Side effects

Common

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Abdominal pain
  • Indigestion / heartburn
  • Fatigue
  • Decreased appetite

Serious — get medical help

  • Pancreatitis (severe stomach pain that may spread to the back)
  • Gallbladder problems, including gallstones
  • Low blood sugar when combined with insulin or a sulfonylurea
  • Kidney problems, often from dehydration after vomiting or diarrhea
  • Serious allergic reactions
  • Diabetic retinopathy complications (people with type 2 diabetes)
  • Pulmonary aspiration during anesthesia or deep sedation — tell your surgical team you take it

Who should not use it

  • Personal or family history of medullary thyroid carcinoma, or MEN 2
  • Prior serious allergic reaction to the drug or its ingredients
  • Pregnancy (stop before a planned pregnancy as advised by your prescriber)
  • Use together with another GLP-1 receptor agonist

Cost

LillyDirect self-pay vials have been about $299/month (2.5 mg), $399 (5 mg) and $449 (higher doses). Verify before filling.

GLP-1 cost without insurance →

How to buy Zepbound legally

  1. Get a prescription from your doctor or a licensed telehealth provider.
  2. Fill it at a licensed pharmacy, or through the manufacturer's self-pay pharmacy.
  3. Verify any online pharmacy first (US: safe.pharmacy; Canada: your provincial pharmacy college register).

Buying legally in the USA → Buying legally in Canada →

Common questions

Frequently asked questions

Zepbound or Wegovy — which causes more weight loss?

In head-to-head data, tirzepatide produced more average weight loss than semaglutide 2.4 mg. Tolerance, coverage and medical history decide which suits a person.

Why are Zepbound vials cheaper?

Lilly sells single-dose vials directly to self-pay patients with a prescription through LillyDirect.

Also searched as: Zepbound pen, Zepbound vial, Zepbound injection, Zepbond, Zepboud, Zepbound tirzepatide, tirzepatide for weight loss, Zepbound price, Zepbound cost, Zepbound LillyDirect, Zepbound sleep apnea, buy Zepbound

Sources

Checked against these primary sources on .

Contact
Esc

↑↓ navigate↵ open